by Robert Hayes Posted on July 3, 2021July 3, 2021 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Acquires Vigene Biosciences For $292.5 Million Read More
by Robert Hayes Posted on May 17, 2021May 17, 2021 BUSINESS BRIEF: Wilmington’s Charles River Labs To Acquire Vigene Biosciences To Enhance Gene Therapy Capabilities Read More
Wilmington Apple 